These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 25284616)

  • 41. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.
    Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT
    Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
    Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T
    Wien Klin Wochenschr; 2018 Jul; 130(13-14):446-455. PubMed ID: 29916054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statin use in cirrhosis and its association with incidence of portal vein thrombosis.
    Amjad W; Jiang Z; Lai M
    J Gastroenterol Hepatol; 2024 May; 39(5):955-963. PubMed ID: 38273643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
    Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: A systematic review and meta-analysis.
    Xian J; Tang Y; Shao H; Wang X; Zhang M; Xing T
    Medicine (Baltimore); 2021 Apr; 100(16):e25439. PubMed ID: 33879676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.
    Violi F; Corazza GR; Caldwell SH; Perticone F; Gatta A; Angelico M; Farcomeni A; Masotti M; Napoleone L; Vestri A; Raparelli V; Basili S;
    Intern Emerg Med; 2016 Dec; 11(8):1059-1066. PubMed ID: 27026379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changing perspectives in portal vein thrombosis.
    Janssen HL
    Scand J Gastroenterol Suppl; 2000; (232):69-73. PubMed ID: 11232496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.
    Luca A; Caruso S; Milazzo M; Marrone G; Mamone G; Crinò F; Maruzzelli L; Miraglia R; Floridia G; Vizzini G
    Radiology; 2012 Oct; 265(1):124-32. PubMed ID: 22891357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index.
    Gaballa D; Bezinover D; Kadry Z; Eyster E; Wang M; Northup PG; Stine JG
    Liver Transpl; 2019 Dec; 25(12):1747-1755. PubMed ID: 31436367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension.
    Kinjo N; Kawanaka H; Akahoshi T; Tomikawa M; Yamashita N; Konishi K; Tanoue K; Shirabe K; Hashizume M; Maehara Y
    Br J Surg; 2010 Jun; 97(6):910-6. PubMed ID: 20474001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort.
    Kondili LA; Zanetto A; Quaranta MG; Ferrigno L; Panetta V; Calvaruso V; Zignego AL; Brunetto MR; Raimondo G; Biliotti E; Ieluzzi D; Iannone A; Madonia S; Chemello L; Cavalletto L; Coppola C; Morisco F; Barbaro F; Licata A; Federico A; Cerini F; Persico M; Pompili M; Ciancio A; Piscaglia F; Chessa L; Giacometti A; Invernizzi P; Brancaccio G; Benedetti A; Baiocchi L; Gentile I; Coppola N; Nardone G; Craxì A; Russo FP;
    United European Gastroenterol J; 2024 Apr; 12(3):352-363. PubMed ID: 38032175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.
    Xu X; Guo X; De Stefano V; Silva-Junior G; Goyal H; Bai Z; Zhao Q; Qi X
    Hepatol Int; 2019 Jul; 13(4):468-481. PubMed ID: 31175581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
    Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
    Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.
    Kukla M; Waluga M; Żorniak M; Berdowska A; Wosiewicz P; Sawczyn T; Bułdak RJ; Ochman M; Ziora K; Krzemiński T; Hartleb M
    World J Gastroenterol; 2017 Apr; 23(14):2613-2624. PubMed ID: 28465646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis.
    Li MX; Zhang XF; Liu ZW; Lv Y
    Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):512-9. PubMed ID: 24103282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Portal vein thrombosis in liver cirrhosis - the added value of contrast enhanced ultrasonography.
    Danila M; Sporea I; Popescu A; Șirli R
    Med Ultrason; 2016 Jun; 18(2):218-33. PubMed ID: 27239658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and outcome of portal thrombosis in a cohort of cirrhotic patients undergoing liver transplantation.
    Hernández Conde M; Llop Herrera E; de la Revilla Negro J; Pons Renedo F; Fernández Puga N; Martínez Porras JL; Trapero Marugan M; Cuervas-Mons V; Sánchez Turrión V; Calleja Panero JL
    Rev Esp Enferm Dig; 2016 Nov; 108(11):716-720. PubMed ID: 27756145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.
    Gao PJ; Gao J; Li Z; Hu ZP; Leng XS; Zhu JY
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):327-332. PubMed ID: 26500198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.
    Wosiewicz P; Żorniak M; Hartleb M; Barański K; Hartleb M; Onyszczuk M; Pilch-Kowalczyk J; Kyrcz-Krzemień S
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):722-729. PubMed ID: 27160816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.